# Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis

> **NCT02785185** · PHASE2 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 150 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** IDP-122 Vehicle Lotion
- **DRUG:** IDP-122 Vehicle Cream
- **DRUG:** IDP-122 Lotion
- **DRUG:** Ultravate Cream

## Key facts

- **NCT ID:** NCT02785185
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2016-12-02
- **Final completion:** 2017-01
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2020-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02785185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02785185, "Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02785185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*